Editing of Hepatitis B Virus DNA by Human APOBEC3 Enzymes
Author Information
Author(s): Henry Michel, Guétard Denise, Suspène Rodolphe, Rusniok Christophe, Wain-Hobson Simon, Vartanian Jean-Pierre
Primary Institution: Institut Pasteur, Paris, France
Hypothesis
Can human APOBEC3 enzymes edit the hepatitis B virus (HBV) genome?
Conclusion
The study found that six out of seven human APOBEC3 enzymes can edit HBV DNA at low frequencies, with A3A being the most efficient.
Supporting Evidence
- All seven APOBEC3 enzymes were tested for their ability to edit HBV DNA.
- A3A was found to be the most efficient editor among the enzymes.
- Editing frequencies ranged from 10−2 to 10−5 in vitro.
- The study utilized a quail cell line that does not produce any endogenous DNA cytidine deaminase activity.
- 3DPCR was used to detect low levels of editing that might not be identified by other methods.
Takeaway
Scientists studied how certain proteins in humans can change the DNA of the hepatitis B virus, and they found that most of these proteins can do this, but not very often.
Methodology
The researchers used a quail cell line to test the editing ability of seven human APOBEC3 enzymes on HBV DNA using a sensitive PCR method.
Limitations
The editing frequencies observed were low, suggesting that they may not exert significant selective pressure on the virus.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website